This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0332U only for EpiSwitch® CiRT (Checkpoint–inhibitor Response Test) from Next Bio–Research Services LLC and Oxford BioDynamics PLC. Using a whole blood specimen from a cancer patient, the test identifies and quantifies eight biomarkers of non–gene (epigenetic) factors that could impact patient response to specific cancer drugs called immune checkpoint inhibitors.
For clinical responsibility, terminology, tips and additional info
start codify free trial.